Health-related quality of life in older patients with heart failure from before to early after advanced surgical therapies: Findings from the SUSTAIN-IT study

Kathleen L. Grady, Northwestern University, Chicago, IL (K.L.G., D.-T.P., A.-C.A., C.E., A.B., C.Y.).
Andrew Kao, St. Luke's Medical Center, Kansas City, MO (A.K.).
John A. Spertus, University of Missouri-Kansas City (J.A.S.).
Eileen Hsich, Cleveland Clinic, OH (E.H.).
Mary Amanda Dew, University of Pittsburgh, PA (M.A.D.).Follow
Duc-Thinh Pham, Northwestern University, Chicago, IL (K.L.G., D.-T.P., A.-C.A., C.E., A.B., C.Y.).
Justin Hartupee, Washington University, St. Louis, MO (J.H.).
Michael Petty, University of Minnesota Medical Center, Minneapolis (M.P.).
William Cotts, Advocate Aurora HealthFollow
Salpy V. Pamboukian, University of Alabama-Birmingham (S.V.P., J.K.K.).
Francis D. Pagani, University of Michigan, Ann Arbor (F.D.P.).
Brent Lampert, Ohio State University, Columbus (B.L.).
Maryl Johnson, University of Wisconsin, Madison (M.J., M.M.).
Margaret Murray, University of Wisconsin, Madison (M.J., M.M.).
Koji Takeda, Columbia University, New York, NY (K.T., M.Y.).
Melana Yuzefpolskaya, Columbia University, New York, NY (K.T., M.Y.).
Scott Silvestry, Florida Hospital, Orlando (S.S.).
James K. Kirklin, University of Alabama-Birmingham (S.V.P., J.K.K.).
Adin-Cristian Andrei, Northwestern University, Chicago, IL (K.L.G., D.-T.P., A.-C.A., C.E., A.B., C.Y.).Follow
Christian Elenbaas, Northwestern University, Chicago, IL (K.L.G., D.-T.P., A.-C.A., C.E., A.B., C.Y.).
Abigail Baldridge, Northwestern University, Chicago, IL (K.L.G., D.-T.P., A.-C.A., C.E., A.B., C.Y.).Follow
Clyde Yancy, Northwestern University, Chicago, IL (K.L.G., D.-T.P., A.-C.A., C.E., A.B., C.Y.).

Affiliations

Advocate Christ Medical Center

Abstract

Background: Restoring health-related quality of life (HRQOL) is a therapeutic goal for older patients with advanced heart failure. We aimed to describe change in HRQOL in older patients (60-80 years) awaiting heart transplantation (HT) with or without pretransplant mechanical circulatory support (MCS) or scheduled for long-term MCS, if ineligible for HT, from before to 6 months after these surgeries and identify factors associated with change.

Methods: Patients from 13 US sites completed the EuroQol 5-dimension 3L questionnaire and Kansas City Cardiomyopathy Questionnaire-12 at baseline and 3 and 6 months after HT or long-term MCS. Analyses included univariate comparisons and multivariable linear regression.

Results: Among 305 participants (cohort mean age=66.2±4.7 years, 78% male, 84% White, 55% New York Heart Association class IV), 161 underwent HT (n=68 with and n=93 without pretransplant MCS), and 144 received long-term MCS. From baseline to 3 months, EuroQol 5-dimension visual analog scale scores improved in HT patients without pretransplant MCS (54.5±24.3 versus 75.9±16.0, PPPPP=0.002). No further HRQOL improvement was found from 3 to 6 months. Factors most significantly associated with change in HRQOL, baseline 3 months, were right heart failure and 3-month New York Heart Association class, and 3 to 6 months, were 6-month New York Heart Association class and major bleeding.

Conclusions: In older heart failure patients, HRQOL improved from before to early after HT and long-term MCS. At 6 postoperative months, HRQOL of long-term MCS patients was lower than one or both HT groups. Understanding change in HRQOL from before to early after these surgeries may enhance decision-making and guide patient care.

Registration: URL: https://www.

Clinicaltrials: gov; Unique identifier: NCT02568930.

Document Type

Article

PubMed ID

36214123

Teammate Access


 

Share

COinS